Sponsored by:

Nuclear Medicine: Page 380

Molecular Imaging CEO resigns
Molecular Imaging founder, chairman, president, and CEO Paul Crowe has resigned to pursue other interests. The company's current executive team will be responsible for day-to-day operations, according to the San Diego-based firm.
September 19, 2004
Image database featured at 2004 SNM meeting
By Jonathan S. Batchelor
A brain image database created by a multinational research team caught the attention of Dr. Henry Wagner, and was selected by the Society of Nuclear Medicine (SNM) as its image of the year at the 2004 annual meeting in Philadelphia.
September 8, 2004
MDS Life Sciences shows Q3 revenue gain
By AuntMinnie.com staff writers
The Life Sciences division of Canadian healthcare firm MDS of Toronto reported growing revenues for its third quarter (end-July 31), although operating income declined.
September 8, 2004
Immunomedics revenues sag
By AuntMinnie.com staff writers
Radiopharmaceutical firm Immunomedics reported fiscal fourth-quarter revenues of $900,000, down 47.1% compared with the $1.7 million posted in the fourth quarter of fiscal 2003.
September 8, 2004
Molecular Insight, University of Maryland get NIH grant
By AuntMinnie.com staff writers
Radioisotope imaging developer Molecular Insight Pharmaceuticals of Cambridge, MA, reported that it has received funding from the National Institutes of Health (NIH) to develop molecular imaging pharmaceuticals to detect and noninvasively monitor the activity of angiotensin-converting enzyme (ACE) in patients with congestive heart failure.
August 26, 2004
Neoprobe extends Japanese distribution deal
By AuntMinnie.com staff writers
Gamma probe developer Neoprobe of Dublin, OH, has extended its agreement with its Japanese distributor to include the company's Quantix product line.
August 24, 2004
Molecular Imaging, CCP sign distribution deal
By AuntMinnie.com staff writers
PET imaging services provider Molecular Imaging has entered into a radiopharmaceutical distribution agreement with Custom Care Pharmacy (CCP) of Tampa, FL.
August 23, 2004
Rowers facing more rib stress factures
By Matt King
Rowing has been a competitive sport since it debuted in England in 1716. It became an international collegiate sport in 1793, and men made their Olympic rowing debut in 1900. Despite all that history, there’s not a great deal of medical literature about rowing injuries. But in recent years, rowers are getting hurt in greater numbers, suffering particularly from stress fractures of the ribs.
August 22, 2004
2004 08 11 16 11 37 706
International Isotopes net loss widens
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes reported second-quarter sales of $467,000, down 40.5% compared with the $785,000 booked in the second quarter of 2003.
August 15, 2004
International Isotopes to trade on OTCBB
By AuntMinnie.com staff writers
Radioisotope manufacturer International Isotopes said its company stock will now be trading on the OTC Bulletin Board (OTCBB) under the symbol INIS.
August 15, 2004
Draxis Health books record revenues
By AuntMinnie.com staff writers
Draxis Health reported record second-quarter revenues of $16.7 million, up 42% compared with the $11.8 million turned in during the second quarter of 2003. For the quarter (end-June 30), the Mississauga, Ontario-based vendor had net income of $2.3 million, compared with net income of $700,000 a year ago.
August 11, 2004
Cardiolite finds ischemia in diabetes patients
By AuntMinnie.com staff writers
Pharmaceutical developer Bristol-Myers Squibb Medical Imaging of North Billerica, MA, is touting the results of a clinical study that found that its Cardiolite heart imaging radiopharmaceutical could be effective in detecting coronary artery disease (CAD) in asymptomatic diabetic patients.
August 8, 2004
Previous Page
Page 380 of 440
Next Page